Peptides, GLP-1s, and the Future of Bio-Writing
An analysis of the shift from passive health monitoring to active biological intervention. This brief covers the market expansion of GLP-1 drugs, the rise of gray-market peptides, and the emerging investment opportunities in neurotechnology and real-time biomarker sensing.